FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Disclosed is a sheet moulding of a polymer composition, comprising at least one protein selected from the group consisting of fibrinogen and thrombin, and at least one polymer selected from the group consisting of an aliphatic polyester and a water-soluble polymer; and a laminated moulded laminate product comprising a first layer of a polymer composition consisting of fibrinogen and a water-soluble polymer, and a second layer of a polymer composition, consisting of thrombin and aliphatic polyester. Said moulded products are applied to a wound site and function as a haemostatic material.
EFFECT: product has good supporting characteristics and solubility for haemostatic proteins and excellent flexibility.
19 cl, 1 dwg, 3 tbl, 31 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STERILE COMPOSITION | 2013 |
|
RU2695522C2 |
| RADIATION-STERILIZATION-RESISTANT PROTEIN COMPOSITION | 2013 |
|
RU2678828C2 |
| LOW-CHARGE FIBRE AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2557623C2 |
| POLYMER-BASED COMPOSITION CONTAINING CYCLIC CARBODIIMIDE | 2009 |
|
RU2538602C2 |
| REINFORCED RESORBABLE SYNTHETIC MATRIX FOR HAEMOSTATIC APPLICATIONS | 2011 |
|
RU2574016C2 |
| HAEMOSTATIC WOUND DRESSING | 2013 |
|
RU2661036C2 |
| METHOD OF MAKING COMPOSITE MOULDED ISLANDS-IN-SEA FIBRES | 2006 |
|
RU2387744C2 |
| FIBRE FROM COMPLETELY AROMATIC METATYPE POLYAMIDE | 2010 |
|
RU2534767C2 |
| ARTIFICIAL DURA MATER AND METHOD OF ITS PRODUCTION | 2010 |
|
RU2491961C2 |
| HEMOSTATIC BIOLOGICALLY ABSORBABLE DEVICE WITH POLYETHYLENE GLYCOL AS A BINDING SUBSTANCE | 2012 |
|
RU2646728C1 |
